ecancer

Exemestane significantly reduces risk of invasive breast cancer in high-risk, postmenopausal women

Dr Paul Goss - Dana-Farber/Harvard Cancer Center, Massachusetts General Hospital, Boston, USA

17 Jun 2011

ASCO 2011 highlights

Prof Gordon McVie – ecancer Managing Editor

16 Jun 2011

Susan G. Komen for the Cure; worldwide breast cancer advocacy

Liz Thompson - Susan G. Komen for the Cure, USA

16 Jun 2011

Partial breast irradiation

Dr Roberto Orecchia – European Institute of Oncology, Italy

6 Jun 2011

Impact of waiting times in head and neck cancer

Dr Cai Grau – The Danish Head and Neck Cancer Group

3 Jun 2011

Breast cancer and early cancer detection in Oman

Dr Alajmi Adil Aljarrah - Sultan Qaboos University Hospital, Muscat, Oman

2 Jun 2011

Reducing global cancer mortality

Prof Peter Boyle - International Prevention Research Institute, Lyon, France

2 Jun 2011

Public-private partnerships in personalised medicine

Dr Andreas Penk - President, European Pfizer Oncology Business Unit

31 May 2011

Eribulin and EMBRACE Study: focus on efficacy and discussion regarding other studies underway and being planned with Eribulin.

Prof Gordon McVie, Prof Chris Twelves

6 May 2011

Eribulin and EMBRACE Study: focus on efficacy, side effect management and patient selection

Prof Gordon McVie, Prof Javier Cortes

6 May 2011

The Cancer Genome Atlas (TCGA)

Dr Paul Spellman - National Cancer Institute, Bethesda, USA

21 Apr 2011

Role of adipose tissue in cancer proliferation

Dr Francesco Bertolini - European Institute of Oncology, Milan, Italy

20 Apr 2011

More from ecancer